🔗 Share this article

Chancellor Reeves has revealed she is preparing "focused action to address household expense challenges" in the forthcoming Budget.

In comments to the BBC, she emphasized that lowering price rises is a shared responsibility of both the administration and the Bank of England.

The United Kingdom's inflation rate is forecast to be the highest among the G7 industrialized countries this calendar year and the following year.

Potential Utility Bill Interventions

Reports indicate the government could intervene to reduce energy bills, for instance by reducing the current 5% level of value-added tax applied on energy.

Another approach is to reduce some of the policy costs currently included in household expenses.

Budgetary Constraints and Analyst Predictions

The administration will obtain the next draft from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much space there is for these actions.

The view from most analysts is that Reeves will have to announce higher taxes or expenditure reductions in order to adhere to her voluntary borrowing rules.

Previously on Thursday, analysis indicated there was a twenty-two billion pound shortfall for the Treasury chief to fill, which is at the more modest range of forecasts.

"There's a collective task between the central bank and the government to further reduce some of the drivers of inflation," the Chancellor informed the BBC in the US capital, at the conferences of the IMF and global financial institution.

Revenue Pledges and International Issues

While a great deal of the attention has been on expected tax increases, the chancellor said the latest information from the fiscal watchdog had not changed her pledge to manifesto promises not to raise tax levels on income tax, sales tax or social security contributions.

She attributed an "unpredictable global environment" with rising geopolitical and commercial tensions for the Budget revenue measures, likely to be targeted on those "most able to pay."

International Economic Disputes

Addressing worries about the UK's trade ties with the Asian nation she said: "Our security interests invariably are paramount."

Last week's declaration by China to strengthen trade restrictions on rare earths and other materials that are crucial for advanced tech manufacturing led US President Donald Trump to suggest an further 100% tariff on imports from China, increasing the possibility of an full-scale trade war between the two global powers.

The US Treasury Secretary labeled the Chinese move "commercial pressure" and "a international production control attempt."

Inquired about accepting the US offer to join its dispute with China, Reeves said she was "very concerned" by Chinese measures and urged the Beijing authorities "to avoid restrictions and restrict access."

She said the action was "bad for the world economy and causes additional obstacles."

"In my view there are areas where we must challenge Chinese policies, but there are also important prospects to trade with China's economy, including banking sector and other areas of the economic system. We've got to achieve that balance correct."

The Treasury chief also affirmed she was working with international partners "regarding our own essential resources approach, so that we are less reliant."

NHS Medicine Costs and Investment

Reeves also recognized that the price the National Health Service spends on medicines could rise as a result of current discussions with the US government and its drugs companies, in return for reduced taxes and funding.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either delaying or abandoning projects in the UK, with some attributing the insufficient payments they are getting.

Last month, the government science advisor said the price the health service pays for drugs would have to rise to halt businesses and drug research funding departing from the UK.

The Chancellor told the BBC: "We have seen due to the payment system, that medical research, recent pharmaceuticals have not been available in the UK in the manner that they are in other European countries."

"The objective is to make sure that patients receiving treatment from the National Health Service are can access the top essential medicines in the world. And so we are looking at this situation, and... seeking to attract additional capital into the UK."